SCM Pharma has been awarded a commercial supply contract by Alliance Pharma to provide filling, packaging and testing of three injectable products. The products include Edrophonium, used in the diagnosis of myasthenia gravis, Isoniazid, used as a first-line anti-tuberculosis prevention and treatment, and Pentagastrin, a diagnostic test for medullary carcinoma of the thyroid. Edrophonium and Isoniazid will be supplied in terminally sterilized ampoules, while Pentagastrin will be aseptically fill...